Hansen JL - Search Results

1

The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling.

Bonde MM, Olsen KB, Erikstrup N, Speerschneider T, Lyngsø C, Haunsø S, Nielsen MS, Sheikh SP, Hansen JL. Bonde MM, et al. Among authors: hansen jl. Regul Pept. 2011 Feb 25;167(1):21-5. doi: 10.1016/j.regpep.2010.11.003. Epub 2010 Nov 27. Regul Pept. 2011. PMID: 21115072

2

Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.

Bonde MM, Hansen JT, Sanni SJ, Haunsø S, Gammeltoft S, Lyngsø C, Hansen JL. Bonde MM, et al. Among authors: hansen jl, hansen jt. PLoS One. 2010 Nov 30;5(11):e14135. doi: 10.1371/journal.pone.0014135. PLoS One. 2010. PMID: 21152433 Free PMC article.

3

Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer?

Hansen JL, Hansen JT, Speerschneider T, Lyngsø C, Erikstrup N, Burstein ES, Weiner DM, Walther T, Makita N, Iiri T, Merten N, Kostenis E, Sheikh SP. Hansen JL, et al. Among authors: hansen jt. J Biol Chem. 2009 Jan 16;284(3):1831-9. doi: 10.1074/jbc.M804607200. Epub 2008 Nov 18. J Biol Chem. 2009. PMID: 19017652 Free article.

4

Loss-of-function polymorphic variants of the human angiotensin II type 1 receptor.

Hansen JL, Haunsø S, Brann MR, Sheikh SP, Weiner DM. Hansen JL, et al. Mol Pharmacol. 2004 Mar;65(3):770-7. doi: 10.1124/mol.65.3.770. Mol Pharmacol. 2004. PMID: 14978256

5

Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits galphaq protein signaling but not ERK activation.

Hansen JL, Theilade J, Haunsø S, Sheikh SP. Hansen JL, et al. J Biol Chem. 2004 Jun 4;279(23):24108-15. doi: 10.1074/jbc.M400092200. Epub 2004 Mar 31. J Biol Chem. 2004. PMID: 15056658 Free article.

6

Functional consequences of 7TM receptor dimerization.

Hansen JL, Sheikh SP. Hansen JL, et al. Eur J Pharm Sci. 2004 Dec;23(4-5):301-17. doi: 10.1016/j.ejps.2004.08.004. Eur J Pharm Sci. 2004. PMID: 15567283 Review.

7

Family C 7TM receptor dimerization and activation.

Bonde MM, Sheikh SP, Hansen JL. Bonde MM, et al. Among authors: hansen jl. Endocr Metab Immune Disord Drug Targets. 2006 Mar;6(1):7-16. doi: 10.2174/187153006776056594. Endocr Metab Immune Disord Drug Targets. 2006. PMID: 16611160 Review.

8

The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferation.

Hansen JL, Aplin M, Hansen JT, Christensen GL, Bonde MM, Schneider M, Haunsø S, Schiffer HH, Burstein ES, Weiner DM, Sheikh SP. Hansen JL, et al. Among authors: hansen jt. Eur J Pharmacol. 2008 Aug 20;590(1-3):255-63. doi: 10.1016/j.ejphar.2008.05.010. Epub 2008 May 20. Eur J Pharmacol. 2008. PMID: 18565507

9

Molecular determinants of angiotensin II type 1 receptor functional selectivity.

Aplin M, Bonde MM, Hansen JL. Aplin M, et al. Among authors: hansen jl. J Mol Cell Cardiol. 2009 Jan;46(1):15-24. doi: 10.1016/j.yjmcc.2008.09.123. Epub 2008 Sep 26. J Mol Cell Cardiol. 2009. PMID: 18848837 Review.

10

An angiotensin II type 1 receptor activation switch patch revealed through evolutionary trace analysis.

Bonde MM, Yao R, Ma JN, Madabushi S, Haunsø S, Burstein ES, Whistler JL, Sheikh SP, Lichtarge O, Hansen JL. Bonde MM, et al. Among authors: hansen jl. Biochem Pharmacol. 2010 Jul 1;80(1):86-94. doi: 10.1016/j.bcp.2010.03.006. Epub 2010 Mar 21. Biochem Pharmacol. 2010. PMID: 20227396 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page